Multiple Flat Champion Oisin Murphy To Make His Jumping Debut

Oisin Murphy, who was three times been crowned champion jockey on the Flat in Britain, will make his debut over hurdles at Wincanton on Thursday.

The 28-year-old, who is also a keen showjumper, has partnered six Group 1 winners in 2023, led by the  QIPCO 1,000 Guineas winner Mawj (Ire) (Exceed And Excel {Aus}) for Godolphin.

His first public spin over jumps comes in the National Hunt Novices' Handicap Hurdle aboard Lets Do This (Ire) for Irish trainer Cian Collins but Murphy has plenty of experience working with jumpers through his uncle Jim Culloty, who rode the treble Cheltenham Gold Cup winner Best Mate (Fr) and also trained the Gold Cup winner Lord Windermere (Ire).

He said, “I worked with [Jim] in my teens, so jump racing has always been part of my life and it has always been a burning ambition of mine to ride in a jumps race.

“I took out a jumps licence earlier in the year, as at one stage it looked like I might get a ride in the Champion Bumper at the Cheltenham Festival.

“The programme of Flat racing means it is unlikely that I will be able to ride over hurdles often, but this opportunity arose as I know the trainer and owner of Lets Do This well. It is only a fairly low-grade handicap hurdle on Thursday, so it seemed like a good place to start.

“I have been schooling horses to prepare, though have not yet ridden Lets Do This.”

Murphy added, “It would be an amazing feeling to get a winner over jumps and I'm not looking beyond Thursday at the moment – I just hope I don't embarrass myself.”

 

The post Multiple Flat Champion Oisin Murphy To Make His Jumping Debut appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

2024 Kentucky Derby Prospect Profiles: Remsen Stakes Winner Dornoch

Welcome to 2024 Kentucky Derby Prospect Profiles, where we’ll take a look each week at a recent winner on the Triple Crown trail, usually from the Road to the Kentucky Derby prep series that offers qualifying points for the first leg of the Triple Crown. The 1 ¼-mile Kentucky Derby Presented by Woodford Reserve will be held May 4, 2024, at Churchill Downs.

Read More...

Source of original post

‘He’s Done His Job’: Hong Kong Superstar Golden Sixty, Now An 8-Year-Old, Readies For International Swansong

Ahead of what shapes as his fourth and final appearance at the LONGINES Hong Kong International Races, Golden Sixty was as enthusiastic as ever at Sha Tin this morning (Monday, 4 December) under former jockey Alex Yu – his regular work rider – while trainer Francis Lui watched on from his traditional vantage point in the trainers' stand.

Aiming to join Good Ba Ba as the only three-time winners of the HK$32 million (US$4 million) G1 LONGINES Hong Kong Mile on Sunday (Dec. 10) after his wins in 2020 and 2021, the 8-year-old Golden Sixty warmed up in the sand ring, then on the inner dirt course before eagerly bouncing onto the main dirt course to work through a key gallop under Yu, clocking a time of 25.7s over 400m.

“He's good. Everything is fine, it's smooth and he's improved with each barrier trial he's had. His condition is very good now,” Lui said. “They're all very happy – Vincent (Ho) and the whole team.”

A 25-time winner from 29 starts, Golden Sixty will commence his sixth season of racing in Sunday's LONGINES Hong Kong Mile. It will be 224 days between runs when he reappears under race conditions with jockey Vincent Ho in front of an adoring home crowd against opposition from Japan, Ireland, France and Singapore.

“He likes to run fresh. His form and even this morning, he'll have a turf gallop on Thursday (7 December). It's been a long time, it's a tough field, especially the Japanese horses. Hopefully he stays away from trouble and gets a clean run,” Lui said.

Golden Sixty has won all of his five seasonal reappearances, however, he's yet to resume at Group 1 level against overseas raiders. The Medaglia d'Oro gelding's last return run saw him defeat California Spangle at Group 2 level, before that horse sensationally reversed the result one start later in the 2022 LONGINES Hong Kong Mile.

Slated for probable retirement in Japan after only a handful of runs this season, Golden Sixty has banked HK$147.93 million (US$18.93 million) in prize money and boasts nine Group 1 wins.

“We're just focused on the big race. We don't know though – let the horse tell me (when it's time to retire). I think so (last Hong Kong International Races) – he's done his job,” Lui said.

Golden Sixty will face 13 rivals this weekend. California Spangle, Beauty Eternal, Serifos, Soul Rush, Tribalist, Voyage Bubble, Cairo, Encountered and Namur are among his opponents.

The post ‘He’s Done His Job’: Hong Kong Superstar Golden Sixty, Now An 8-Year-Old, Readies For International Swansong appeared first on Horse Racing News | Paulick Report.

Source of original post

New York Commission Votes To Uphold Forte’s Hopeful DQ, Pletcher’s 10-Day Suspension

The New York State Gaming Commission voted unanimously on Monday to upholds Forte's disqualification from the 2022 Hopeful Stakes (G1) over a positive test for meloxicam, reports the Thoroughbred Daily News. The decision sustaining a hearing officer's report also upholds a 10-day suspension and $1,000 fine for Hall of Fame trainer Todd Pletcher.

On May 9, 2023, just days after Forte was scratched as the favorite on the morning of the Kentucky Derby, the New York Times broke the news that the colt had a drug positive still pending from his juvenile season. Adjudication of the positive dragged on; a spokesperson for the New York State Gaming Commission told Drape the delays were “sought by the trainer's counsel.”

Meanwhile, after his win in the Hopeful, Forte went on to capture the G1 Breeders' Futurity at Keeneland, followed by the Breeders' Cup Juvenile, earning him the 2022 Eclipse Award for Champion 2-Year-Old Colt.

The NYSGC officially announced the disqualification on May 11, which owner Mike Repole appealed. Pletcher stated during a media conference that the colt had never been prescribed or knowingly treated with meloxicam.

A hearing was held on July 20, and the hearing officer issued his report on Sept. 30, upholding the disqualification and penalties.

Owner Mike Repole told the Thoroughbred Daily News on Monday that he plans to take advantage of his right to appeal the NYSGC decision in the New York court system.

“We plan on taking this further and we knew we were going to get to this point,” Repole told TDN. “Under HISA rules, this isn't even a violation. We are super confident that common sense will prevail and people will realize we put in this governing body in HISA to make sure people are ethical and play by the rules of the sport. Any real process that follows common sense will easily see it the same way and we will prevail.”

Though HISA's Anti-Doping and Medication Control program was not in place at the time of the positive test (it launched on May 22, 2023), Repole's statement appears to fit with a statement from HISA CEO Lisa Lazarus.

In May, Lazarus referenced a report in bloodhorse.com in which Steven Barker, a chemist, LSU professor, and expert witness for Forte's connections, indicated that 500 picograms (or 0.5 nanograms) of meloxicam was found in the colt's system after the running of the 2022 Grade 1 Hopeful Stakes. Lazarus told the TDN that amount would not have triggered a positive under HISA's Anti-Doping and Medication Control Program rules, which launched May 22.

“I'm not going to talk about Forte specifically, but what I will tell you is that HISA's screening limits from meloxicam track the International Federation of Horseracing Authorities' screening limits,” Lazarus told TDN. “Therefore, our screening limit is one nanogram per milliliter in blood and 10 nanograms per milliliter in hydrolyzed urine. If what has been reported – and I haven't verified this — but if that positive was [indeed] 500 picograms, that would be below our screening limit and would not ever be notified as a positive under HISA.”

Meloxicam is a non-steroidal anti-inflammatory (NSAID), according to Medlineplus.gov, which is used in human medicine “to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints).”

The Association of Racing Commissioners International classifies Meloxicam as a Class 4, Penalty Class B drug. Class 4 drugs are therapeutic medications that would be expected to have less potential to affect performance than those in Class 3. Drugs in this class includes less potent diuretics; corticosteroids; antihistamines, and skeletal muscle relaxants without prominent central nervous system (CNS) effects; expectorants and mucolytics; hemostatics; cardiac glycosides and anti-arrhythmics; topical anesthetics; antidiarrheals and mild analgesics. This class also includes the non-steroidal anti-inflammatory drugs (NSAIDs), at concentrations greater than established limits.

Read more at the Thoroughbred Daily News.

The post New York Commission Votes To Uphold Forte’s Hopeful DQ, Pletcher’s 10-Day Suspension appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights